These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20100008)

  • 21. gamma-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Mo R; Meyer DT; Voss ME; Yang MG; Santella JB; Duncia JV; Lo YC; Yang G; Miller PB; Scherle PA; Zhao Q; Mandlekar S; Cvijic ME; Barrish JC; Decicco CP; Carter PH
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2425-30. PubMed ID: 20346664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties.
    Butora G; Morriello GJ; Kothandaraman S; Guiadeen D; Pasternak A; Parsons WH; MacCoss M; Vicario PP; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4715-22. PubMed ID: 16870431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2).
    Carter PH; Brown GD; Friedrich SR; Cherney RJ; Tebben AJ; Lo YC; Yang G; Jezak H; Solomon KA; Scherle PA; Decicco CP
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5455-61. PubMed ID: 17720492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases.
    Zhao Q
    J Leukoc Biol; 2010 Jul; 88(1):41-55. PubMed ID: 20360402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QSAR studies on CCR2 antagonists with chiral sensitive hologram descriptors.
    Nair PC; Srikanth K; Sobhia ME
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1323-30. PubMed ID: 18258426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Mo R; Meyer DT; Pechulis AD; Guaciaro MA; Lo YC; Yang G; Miller PB; Scherle PA; Zhao Q; Cvijic ME; Barrish JC; Decicco CP; Carter PH
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6181-4. PubMed ID: 22939233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
    Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
    J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation of the estrogenic activity of stilbestrol by spiro (cyclohexane-1,2'-indan)-1',4-dione.
    Bailey DJ; Doggett NS; Ng LY; Qazi T
    J Med Chem; 1976 Mar; 19(3):438-9. PubMed ID: 1255671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2.
    Shin N; Baribaud F; Wang K; Yang G; Wynn R; Covington MB; Feldman P; Gallagher KB; Leffet LM; Lo YY; Wang A; Xue CB; Newton RC; Scherle PA
    Biochem Biophys Res Commun; 2009 Sep; 387(2):251-5. PubMed ID: 19576173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel sulfone-containing di- and trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Mo R; Meyer DT; Voss ME; Lo YC; Yang G; Miller PB; Scherle PA; Tebben AJ; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3418-22. PubMed ID: 19481449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and preclinical characterization of (+)-3-[4-(1- piperidinoethoxy)phenyl]spiro[indene- 1,1'-indane]-5,5'-diol hydrochloride: a promising nonsteroidal estrogen receptor agonist for hot flush.
    Watanabe N; Ikeno A; Minato H; Nakagawa H; Kohayakawa C; Tsuji J
    J Med Chem; 2003 Sep; 46(19):3961-4. PubMed ID: 12954049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of novel CCR2 antagonists: investigation of non-aryl/heteroaryl binding motifs.
    Trujillo JI; Huang W; Hughes RO; Rogier DJ; Turner SR; Devraj R; Morton PA; Xue CB; Chao G; Covington MB; Newton RC; Metcalf B
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1827-31. PubMed ID: 21316220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent benzimidazolone-based CGRP receptor antagonists.
    Theberge CR; Bednar RA; Bell IM; Corcoran HA; Fay JF; Hershey JC; Johnston VK; Kane SA; Mosser S; Salvatore CA; Williams TM; Zartman CB; Zhang XF; Graham SL; Vacca JP
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6122-5. PubMed ID: 18947992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists.
    Zheng Y; Qin L; Zacarías NV; de Vries H; Han GW; Gustavsson M; Dabros M; Zhao C; Cherney RJ; Carter P; Stamos D; Abagyan R; Cherezov V; Stevens RC; IJzerman AP; Heitman LH; Tebben A; Kufareva I; Handel TM
    Nature; 2016 Dec; 540(7633):458-461. PubMed ID: 27926736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2).
    Yang MG; Xiao Z; Shi Q; Cherney RJ; Tebben AJ; De Lucca GV; Santella JB; Mo R; Cvijic ME; Zhao Q; Barrish JC; Carter PH
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1384-7. PubMed ID: 22225639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists.
    Subasinghe NL; Lanter J; Markotan T; Opas E; McKenney S; Crysler C; Hou C; O'Neill J; Johnson D; Sui Z
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1063-9. PubMed ID: 23294701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.
    Xue CB; Wang A; Meloni D; Zhang K; Kong L; Feng H; Glenn J; Huang T; Zhang Y; Cao G; Anand R; Zheng C; Xia M; Han Q; Robinson DJ; Storace L; Shao L; Li M; Brodmerkel CM; Covington M; Scherle P; Diamond S; Yeleswaram S; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7473-8. PubMed ID: 21036044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokine receptor CCR2 undergoes transportin1-dependent nuclear translocation.
    Favre N; Camps M; Arod C; Chabert C; Rommel C; Pasquali C
    Proteomics; 2008 Nov; 8(21):4560-76. PubMed ID: 18846510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis.
    Min SH; Wang Y; Gonsiorek W; Anilkumar G; Kozlowski J; Lundell D; Fine JS; Grant EP
    Biochem Biophys Res Commun; 2010 Jan; 391(1):1080-6. PubMed ID: 20004647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple binding sites for small-molecule antagonists at the CC chemokine receptor 2.
    Zweemer AJ; Nederpelt I; Vrieling H; Hafith S; Doornbos ML; de Vries H; Abt J; Gross R; Stamos D; Saunders J; Smit MJ; Ijzerman AP; Heitman LH
    Mol Pharmacol; 2013 Oct; 84(4):551-61. PubMed ID: 23877010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.